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Human astrovirus nonstructural C-terminal nsP1a protein, which contains a hypervariable region (HVR) and colocalizes with the
endoplasmic reticulum and viral RNA, has been suggested to be involved in the RNA replication process. Four viruses differing only in their
C-terminal nsP1a protein, corresponding to HVR-derived genotypes IV, V, VI, and XII, were all able to replicate in CaCo-2 cells but
displayed differences in their RNA replication and growth properties. Two overall patterns of replication were observed: types IV and V on
one side, and types VI and XII on the other. The main detected differences were on the levels of antigenomic and subgenomic RNAs, being
the latter significantly higher in types IV and V. Accordingly, quantification of viral RNA load in feces from children with gastroenteritis
showed that HVR-derived genotypes IVand Voccur in significantly higher numbers. In consequence, it may be concluded that the variability
of the C-terminal nsP1a gene affects the virus replication phenotype.
D 2005 Elsevier Inc. All rights reserved.
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leading causes of childhood gastroenteritis worldwide
(Glass et al., 1996; Walter and Mitchell, 2003). These
non-enveloped positive-strand RNA viruses belong to the
family Astroviridae, which includes both mammalian and
avian viruses. Their 6.8-kb polyadenylated genome contains
three overlapping open reading frames (ORFs) (Jiang et al.,
1993): ORF1a and ORF1b, which are linked by a transla-
tional ribosomal frameshifting and encode the viral protease
and polymerase, respectively, and ORF2, which encodes the
capsid precursor (Matsui and Greenberg, 2001).
Upon infection, two large nonstructural proteins are
translated from the genomic RNA (nsP1a and nsP1a/1b),
which mature by proteolysis giving rise to the viral proteins
implicated in the transcription of a full-length negative-
strand RNA molecule (antigenomic RNA). It is believed
that this RNA molecule serves as a template for the
transcription of both the new full-length 6.8-kb-genomic
and the ORF2-containing 2.4-kb-subgenomic RNA mole-
cules (Matsui et al., 2001). Translation of this subgenomic0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: abosch@ub.edu (A. Bosch).RNA is used to produce large amounts of structural proteins
for the efficient assembly of progeny viruses (Monroe et al.,
1991). The precursor and mature products resulting from
the HAstV nonstructural polyprotein processing have only
been partially characterized, and some of the reported data
are still conflicting (Geigenmu¨ller et al., 2002; Gibson et
al., 1998; Kiang and Matsui, 2002; Me´ndez et al., 2003;
Willcocks et al., 1999). At present, it is believed that nsP1a
and nsP1a/1b polyproteins are proteolytically processed by
both cellular and viral proteases, giving rise to at least five
products, which could be even further processed (see
Fig. 3). Using antibodies against approximately 30% of
nsP1a C-terminal region, different authors have identified
products of 34, 20, 6.5, and 5.5 kDa (Me´ndez et al.,
2003; Willcocks et al., 1999). In our laboratory,
immunoprecipitation studies using an antibody against a
synthetic peptide of the C-terminal nsP1a sequence (Guix
et al., 2004a) led to the detection of five proteins in the
range of 21–27 kDa, and at least one of them could be
post-translationally modified by phosphorylation on its
serine and threonine residues (Guix et al., 2004b).
Close to the C-terminus end of nsP1a polyprotein and
contained within the putative C-terminal nsP1a protein, a05) 124–131
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(HVR, nucleotides 2363–2554 of HAstV1 ORF1a, acces-
sion no. L23513), but its biological significance remains
unknown (Me´ndez-Toss et al., 2000; Oh and Schreier, 2001;
Willcocks et al., 1994). Recent results obtained in our
laboratory indicate that the C-terminal nsP1a protein, named
in those studies nsP1a/4, colocalizes with the endoplasmic
reticulum-derived membranes and with viral RNA, suggest-
ing a potential role in the replication process (Guix et al.,
2004b). Interestingly, within the HVR, Willcocks et al.
(1994) described a 45-nt deletion, which was associated to
the adaptation of HAstV to certain cell lines. Additionally,
this HVR is contained in an immunoreactive epitope
(Matsui et al., 1993). A nuclear localization signal (NLS)
and a death domain (DD) have also been described upstream
of the HVR (Guix et al., 2004a, 2004b; Jiang et al., 1993).
Since viral replicative functions are encoded by ORF1a
and ORF1b, and since all complete HAstV genome
sequences available at GenBank are highly conserved
throughout all the nonstructural proteins with the exception
of the C-terminal nsP1a HVR, it seems likely that this
region could influence the viral RNA replication properties.
This work aimed to understand the relationship between the
high degree of genetic variability found in the C-terminal
nsP1a protein and the efficiency in viral replication.
Different mutants have been constructed and characterized
with respect to growth in cell culture and RNA synthesis.Results
Analysis of the genetic variability: association between
HVR-derived genotypes and viral RNA load in fecal samples
To accurately define the extent of genetic variability
within the HVR described in the C-terminal nsP1a protein,
this region was sequenced from a collection of 46 HAstV
isolates belonging to different serotypes. Many in-frame
insertions and deletions (indels) were found within this
region, as well as many nucleotide substitutions, without
complete correlation with serotype information. Approx-
imately 50% of nucleotide substitutions resulted in a change
of amino acid, and only 9% of all the variable positions
induced conservative amino acid substitutions. Based onFig. 1. Amino acid alignment of the HVR (positions 768–823 for type IV, 768–816
C-terminal nsP1a protein. Most prevalent sequences within each type are presen
different patients (n) are calculated. Asterisks depict significantly higher titers atHVR nucleotide genetic variability, different C-terminal
nsP1a protein HVR-derived genotypes were established,
according to its indel pattern and the following definition: p-
distance between all sequences within each genotype should
be lower than 7% and between different genotypes should
be higher than 7%. Using these criteria, a total of 15 HVR-
derived genotypes were identified and named using roman
numerals (manuscript in preparation). The analyzed HAstV
isolates were classified into five HVR-derived genotypes (I,
II, IV, V, VI). Most prevalent amino acid sequences within
each genotype are presented in Fig. 1.
Information on the virus load present in stool suspen-
sions could be obtained in 33 out of the 46 fecal samples by
competitive RT-PCR (Fig. 1). An analysis of variance
(ANOVA) of the number of genomes per gram of feces in
samples belonging to different HVR-derived genotypes
revealed that genotypes IV (11.96 F 0.35) and V (11.92 F
0.43) occurred in significantly higher numbers (P b 0.05)
(Fig. 1). The time of collection, which could be relevant in
terms of the viral load, should not influence the differences
regarding virus titers observed between genotypes, since all
samples had been randomly collected between days 1 and 3
after the onset of symptoms.
A definitive relationship between fecal viral load and
HVR-derived genotype cannot be established from these
data, since other genomic regions could also be responsible
for the observed differences between them. However, the
putative involvement of the nonstructural protein encoded
by this region in viral RNA replication (Guix et al., 2004b),
as well as its high degree of variability compared with the
high degree of conservation for the rest of the region, could
partially explain the differences in the titer found in feces
between different HVR-derived genotypes.
Generation of recombinant astroviruses differing in their
C-terminal nsP1a protein
In order to rule out the possibility that other parts of the
genome could also participate in modulating the efficiency of
RNA replication, three mutant astroviruses with different C-
terminal nsP1a coding genes were generated using the
HAstV1 reference strain full genome-length cDNA clone
pAVIC (Geigenmu¨ller et al., 1997). Three strains correspond-
ing to different HVR-based genotypes (IV, V, and VI) werefor types V and I, 768–822 for type II, and 768–829 for type VI) within the
ted, and the mean titers of viral genomes per gram of feces obtained from
P b 0.05.
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amplify its C-terminal nsP1a coding region and clone it
within HAstV1 cDNA. Due to the low transfection efficiency
described for CaCo-2 cell line, infectious RNA transcripts
synthesized from every clonewere first introduced into BHK-
21 cells using the strategy described by Geigenmu¨ller et al.
(1997). Infectious viruses produced within BHK-21 cells
were recovered in the presence of trypsin and were amplified
by serial passages on CaCo-2 cells. These viruses thus
corresponded to HVR-types IV, V, and VI, as well as XII
which was obtained by direct transfection with the RNA
produced from the original pAVIC.
Final mutant virus stocks were analyzed by sequencing
approximately 90% of the replaced C-terminal nsP1a coding
region. All viruses had introduced some nucleotide sub-
stitutions, which resulted in amino acid changes. In particular,
in type IV mutant, residue Pro661 was replaced by Leu661. In
type V, Ile616 was replaced by Thr616; Glu772 was replaced by
Asp772; Gln792 was replaced by His792; and Ser799 was
replaced by Pro799. In type VI, His803 was replaced by Gln803
(amino acid positions are numbered according to HAstV-1
Oxford reference strain accession no. L23513). Except those
at positions 616 and 661, all mutations involved residues
included in the HVR, which is prone to variability.
Comparison of virus productivity between different HAstV1
HVR-derived genotypes
In order to elucidate the specific effects of the genetic
variability of the HVR on viral growth and RNA replication,
CaCo-2 cells were infected with different HAstV-1 mutantsFig. 2. Analysis of viral RNA titers found within CaCo-2 cells infected by diffe
titers were measured by end-point dilution RT-PCR and are expressed as the log
were independently performed for each kind of RNA form. Common capital lette
shown represent the average of three experiments, each titrated in duplicate.obtained (genotypes IV, V, and VI) using the original
HAstV1 (genotype XII) as a control. Virus productivity and
RNA replication properties were evaluated by measuring the
titer of infectious virus in the supernatant of infected cells
and by titrating the different types of RNA molecules
extracted from intracellular membranes of infected cultures
at 48 h pi (genomic RNA, antigenomic RNA, and
subgenomic RNA). Primers from the ORF1a HVR were
used to detect both the genomic and antigenomic RNA
strands, while primers from ORF2 were used to detect the
total positive-stranded RNA present within the cell, which
includes both the genomic and subgenomic RNA molecules.
The subgenomic positive RNA strands were calculated after
subtracting genomic RNA titer from total RNA titer. Results
of genomic RNA, antigenomic RNA, and subgenomic RNA
titers are summarized in Fig. 2, as well as the infectious titer
of viruses released to the supernatant of infected cells.
Regarding genomic RNA, only the titer showed by type VI
was significantly higher than that of type IV, while no
differences were detected between the rest of genotypes.
Two clear patterns were observed with respect subgenomic
RNA. The one shared by genotypes IV and V, with higher
titers, and the one of genotypes VI and XII, with
significantly lower titers. Finally, the antigenomic titer of
genotype V was significantly lower than that of genotypes
VI and XII.
Alternatively, percentages of genomic, antigenomic, and
subgenomic RNAs were also calculated, as shown in Table
1. HVR-derived genotype VI mutant exhibited a higher
percentage of genomic RNA and a lower percentage of
subgenomic RNA than genotypes IV and V. While forrent HAstV1 mutants belonging to HVR-types IV, V, VI, and XII. RNA
of RT-PCR units per 3  106 cells. ANOVA comparisons between mutants
rs above bars indicate lack of statistical difference ( P b 0.05). The values
Table 1
Percentages of cell-associated RNAs in different HVR type mutants
HVR type Genomic RNA Subgenomic RNA Antigenomic RNA
IV 2.20 F 1.50A 95.71 F 3.19A 2.09 F 1.69A
V 13.58 F 15.59A 85.32 F 17.24A 1.10 F 1.70A
VI 80.30 F 8.48B 0.80 F 0.08B 18.90 F 8.57AB
XII 25.04 F 21.63A 17.34 F 23.82B 34.73 F 26.24B
Percentages of genomic RNA, subgenomic RNA, and antigenomic RNA
were estimated from a total RNA population which was the sum of all three
types of RNAs figured as RT-PCRu/3  106 cells. Mean F SD were
calculated from three independent experiments, each titrated in duplicate.
Common capital letters in superscript indicate lack of statistical difference
( P b 0.05).
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total positive-stranded RNA corresponded to subgenomic
RNA, genotype VI produced essentially genomic RNA
(80.30%) and hence limited amounts of subgenomic RNA.
As a result, the titer of infectious progeny detected in the
supernatant of genotype VI-infected cultures was signifi-
cantly lower than that of genotype V and unexpectedly
similar to that of genotype IV.
Thus, under identical conditions of infection and
compared with types IV and V, type VI displayed differentFig. 3. Amino acid sequence analysis of the C-terminal nsP1a coding region rep
proteins encoded by HAstV ORF1a and ORF1b. The cleavage sites of nsP1a repor
al. (2003) are indicated by black, open, and gray arrowheads, respectively. These
protease (pro). Predicted transmembrane helices (TM), protease motif (PRO), predi
epitope (IRE), hypervariable region (HVR), and ribosomal frameshifting (RFS) b
Oxford reference strain (type XII) and types IV, V, and VI mutants. Hypervariable
phosphorylation and/or O-glycosylation are shown in shadow and underlined, resp
reference strain (accession no. L23513).replication properties. Type XII, employed in these studies
as control, showed an intermediate replication pattern with
regard to that of genotypes IV and V on the one hand and
genotype VI on the other.
Proteomic characterization of mutants
Amino acid changes in the C-terminal nsP1a protein
between the different HAstV1 mutants are shown in Fig. 3.
Along the sequenced region, there were a total of 20
variable amino acid positions and 4 indels. All indels and
most amino acid substitutions were located, as expected,
within the HVR. According to physicochemical properties
of amino acid substitutions, 45% of amino acid changes
were conservative, 30% were semi-conservative, and 25%
were non-conservative. Interestingly, some of these amino
acid substitutions altered the number and position of the
potentially phosphorylated sites of the HVR. Similarly,
some of the detected substitutions affected the glycosylated
sites. Comparisons among genotypes revealed that the
serine phosphorylation sites included into the HVR showed
a tendency to vary following a pattern, in which higher
numbers of phosphoserine sites were associated with higherlaced to generate the HAstV1 mutants. (A) Diagram of the nonstructural
ted by Geigenmu¨ller et al. (2002), Kiang and Matsui (2002), and Me´ndez et
cleavages seem to be dependent on both cellular proteases (?) and the viral
cted nuclear localization signal (NLS), death domain (DD), immunoreactive
etween ORF1a and ORF1b are shown. (B) Sequence alignment of HAstV1
region is boxed and sites liable to be post-translationally modified either by
ectively. Amino acid positions are numbered according to HAstV1 Oxford
S. Guix et al. / Virology 333 (2005) 124–131128and lower percentages of antigenomic and subgenomic
RNAs, respectively (Table 2).
Although some extra point mutations appeared during
the cloning procedure, as above stated, most of them were
included in the HVR and none of them affected the
phosphorylation and glycosylation sites.Discussion
This work reports the effect of the genetic variability
found within HAstV C-terminal nsP1a protein on viral
growth and RNA replication. Different HVR-derived
genotypes with distinct in-frame insertions and deletions
have been established (manuscript in preparation), and three
mutant viruses belonging to three out of these genotypes
(types IV, V and VI ) were constructed and assayed in
comparison with the original type XII. Functional analysis
of these mutants indicated that, compared to types IV and V,
types VI and XII display a different behavior regarding viral
RNA replication and viral growth. These differences in viral
replication properties found between HAstV HVR-derived
genotypes support the previously suggested role of this
protein in modulating viral RNA replication (Guix et al.,
2004b). Although the complete sequence of the recombinant
viruses was not analyzed and hence the occurrence of
mutation in other parts of the genome affecting the
replication pattern cannot be completely ruled out, since
no mutations were observed after sequencing a short
fragment of the capsid (Noel et al., 1995), we assumed a
low level of variation outside the HVR, as it can also be
inferred after aligning the database sequences (data not
shown). Within the same region, Willcocks et al. identified
an in-frame 15-amino acid deletion related to the virus
replication in certain cell lines other than CaCo-2 cells and
not found in stool isolates (Willcocks et al., 1994). In the
present study, this deletion was observed in both stool
isolates and viruses adapted to CaCo-2 cells too, providing
further evidence on the high variability of this region. Thus,
this high degree of variability within the HVR and its
association with different levels of RNA replication suggest
a role of the C-terminal nsP1a protein in RNA replication,
perhaps via interaction with viral and/or host-specific factors
which could modulate the efficiency of RNA replication.
The C-terminal nsP1a protein colocalizes with the endo-Table 2
Number of potentially phosphorylated or glycosylated residues in different HVR-
Genotype Phosphorylation
Inside HVR Outside HVR
Tyr Ser Thr Tyr Se
IV 0 2 1 5 3
V 0 2 2 5 3
VI 0 3 2 5 3
XII 0 4 2 5 3plasmic reticulum-derived membranes and with viral RNA
(Guix et al., 2004b). No differences in the localization of
this protein have been observed between wild-type viruses
belonging to different HVR-derived genotypes (data not
shown), suggesting similar kinds of interactions.
Our results suggest the occurrence of two general
patterns of modulation of RNA replication: on one hand
the pattern shared by genotypes IV and V, and on the other
the one showed by genotypes VI and XII. According to the
accepted model, from the full-length genomic positive
strand, the viral RNA polymerase copies a full-length
negative antigenomic strand that acts as an intermediate
for the final synthesis of the full-length genome and the
subgenomic RNA (Lewis et al., 1994; Matsui et al., 2001;
Monroe et al., 1991, 1993). Within this context, genotypes
VI and XII, which synthesize lower numbers of subgenomic
RNA and thus lower numbers of templates to produce
structural proteins for encapsidation, should as well produce
lower numbers of infectious progeny, as it is the case. On
the contrary, genotypes IV and V, whose subgenomic RNA
is as high as 85–95% of the total RNA, produce higher
infectious progenies. However, the differences in infectivity
titers between both patterns were not as high as one could
expect from the subgenomic RNA levels. No explanation
for this may be provided, not even after analyzing by ELISA
the total structural proteins produced (data not shown). It
might be hypothesized a higher capacity for cellular shut-off
induction and thus an enhanced availability for the trans-
lation machinery that could compensate the lower sub-
genomic levels in genotypes VI and XII. Further
experimental studies are required to provide more light in
this issue.
Regulation of efficient minus and plus RNA strands,
including the synthesis of a subgenomic RNA, is a complex
process that involves many interactions of viral RNA with
different virus and host proteins. Since the replication and
transcription scheme postulated for astrovirus are inferred
from the well-characterized life cycle of alphaviruses such
as Sindbis virus and given the sequence similarity that has
been observed between HAstV C-terminal nsP1a protein
and alphavirus nsP3 (Guix et al., 2004b), functional
parallelisms could be hypothesized between these two
nonstructural proteins. Although the functions of the
alphavirus nsP3 protein are not well defined, it has been
shown to be extremely rich in insertions and deletions.derived genotypes distributed inside or outside the HVR
Glycosylation
Inside HVR Outside HVR
r Thr Ser Thr Ser Thr
0 2 2 2 4
0 1 3 2 3
0 4 2 3 3
0 0 0 2 2
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negative-strand RNA and subgenomic RNA has been
suggested (LaStarza et al., 1994). In addition, it seems to
be regulated by multiple Ser/Thr phosphorylation sites (Li et
al., 1990). Moreover, mutations that affect some phosphor-
ylation sites of alphavirus nsP3 significantly reduced the
rate of viral RNA synthesis and exhibited greatly reduced
pathogenicity in mice (Tuttila and Hinkkanen, 2003;
Vihinen et al., 2001). Similar functional properties could
be postulated for HAstV C-terminal nsP1a protein, since
different patterns of serine phosphorylation sites within the
HVR have been predicted for the studied astrovirus HVR-
derived genotypes. Further investigations in the laboratory
will be focused on these issues.
Interestingly, after quantifying the titer of viral genomes
in stool specimens from children with gastroenteritis
infected by distinct HVR-derived genotypes, differences in
viral loads were found depending on the pattern of
insertions and deletions. Consistently, in samples containing
genotypes IV and V, a significantly higher viral titer was
observed and, for genotype IV, which corresponded to
serotype 3 strains, a correlation with persistent and severe
gastroenteritis was also observed (Caballero et al., 2003).
The differences in virus titer were not the result of the time
after the onset of symptoms in which samples were
collected, since it was randomly distributed among the
genotypes, or of the total volume of feces, because no
differences were observed, with the sole exception of feces
with genotype IV that were shed in higher volumes and
contained higher virus numbers per milliliter. Although the
clinical significance of the higher viral titers in the feces of
individuals infected with genotype IV is not fully under-
stood, we hypothesize that it may be regulated by the C-
terminal nsP1a protein.Materials and methods
Cells and viruses
The human colon adenocarcinoma cell line CaCo-2 was
grown in Eagle’s minimum essential medium (MEM)
supplemented with 10% fetal bovine serum (FBS) and
was used to propagate HAstV strains, as previously
described (Pinto´ et al., 1994). Baby hamster kidney cells
(BHK-21) were grown in MEM, supplemented with 10%
FBS and 1 mM pyruvic acid sodium salt, and were used to
transfect HAstV RNA and produce infectious viruses
(Geigenmu¨ller et al., 1997).
HAstV stool specimens and quantification of viral titer
A panel of 46 HAstV containing stool specimens from
children with gastroenteritis was collected from an epide-
miological study carried out in Spain (Guix et al., 2002),
and was used to study the genetic variability. The number ofHAstV genomic RNA molecules per gram of feces was
obtained by competitive RT-PCR using an internal standard,
as previously described (Caballero et al., 2003).
Sequence analysis and genotype definition
Primers A1 (5V-CCTGCCCCGAGAACAACCAAGC-3V,
nucleotide positions 2363–2384 according to accession no.
L23513) and A2 (5V-GTAAGATTCCCAGATTGGTGC-3V,
nucleotide positions 2534–2554 according to accession no.
L23513) were used to amplify and sequence the HVR of the
C-terminal nsP1a gene, as previously described (Guix et al.,
2002; Willcocks et al., 1994). RT-PCR products of the
expected size, ranging from 192 to 237 bp, were purified
using a commercial kit (High Pure PCR Product Purification
Kit, Roche) and were directly sequenced in an ABI Prism
377 automated DNA sequencer (Applied Biosystems),
using the ABI Prism BigDye Terminator Cycle Sequencing
Ready Reaction Kit v3.1 (Applied Biosystems). Sequence
alignments were performed using CLUSTALW (Higgins et
al., 1994). In nucleotide alignments, positions of insertions
and deletions (indels) were manually corrected according to
their position in amino acid alignments. Nucleotide and
amino acid distances were calculated as the number of
substitutions per site (p-dist) using pairwise deletion for
treating indels with the MEGA2.1 program (Kumar et al.,
1993). According to genetic information provided by both
indels and nucleotide distances, HAstV genetic types were
defined so that all sequences within each type shared a
common indel pattern, and so that nucleotide distances were
lower than 7% within each type and higher than 7%
between different types. Established HVR-derived geno-
types were named with roman numerals. Based on the
amino acid sequence, predicted post-translational modifica-
tions were also analyzed. Phosphorylation sites were
predicted using the NetPhos 2.0 Server, considering a
significance level of 0.9 (http://www.cbs.dtu.dk/services/
NetPhos/) (Blom et al., 1999). O-h-GlcNAc O-linked
glycosylation sites were predicted using the YinOYang 1.2
Server (http://www.cbs.dtu.dk/services/YinOYang/) (Gupta
and Brunak, 2002).
Mutant viruses production
Mutagenesis of the C-terminal nsP1a gene coding region
was performed using the HAstV1 cDNA clone pAVIC
(HVR-type XII; kindly provided by S. M. Matsui, VA Palo
Alto Health Care System, Palo Alto, USA; Geigenmu¨ller et
al., 1997). DNA cloning was carried out using established
procedures (Sambrook et al., 1982). A region of 963
nucleotides (from nucleotide 1652 to 2614 of HAstV-1,
accession no. L23513) was amplified from different wild
type HAstV strains (types IV, V, and VI) using specific
primers containing the sequence of the restriction sites for
BlgII and AgeI enzymes (5V-AATGAAGATCTTGTGG-
TTTC-3V and 5V-AGTCAACCGGTGTGGCGCTG-3V; the
S. Guix et al. / Virology 333 (2005) 124–131130underlined indicate the restriction site introduced in each
primer). The equivalent region of pAVIC plasmid was
excised by digestion with the same pair of restriction
enzymes. Recombinant pAVIC-IV, pAVIC-V, and pAVIC-
VI plasmids were constructed by ligation of the restricted
PCR fragments into BlgII- and AgeI-digested pAVIC. All
resulting constructs were confirmed by DNA sequence
analysis.
In vitro transcription of pAVIC, pAVIC-IV, pAVIC-V,
and pAVIC-VI plasmids was performed using the T7 Cap
Scribe kit (Roche), after linearization of 0.5 Ag of each
plasmid with the unique XhoI restriction site. Finally,
infectious viruses were obtained after electroporation of
20 Al of transcribed RNA into BHK-21 cells using a Bio-
Rad Gene Pulser. Briefly, subconfluent cell monolayers
were trypsinized, washed with phosphate-buffered saline
(PBS), and cooled on ice before being resuspended in ice-
cold buffer (21 mM HEPES buffer [pH 7.05], 137 mM
NaCl, 5 mM KCl, 0.7 mM Na2HPO4, and 6 mM glucose).
Subsequently, 2  106 cells were electroporated in a cuvette
gap of 0.4 cm and a final volume of 0.8 ml, at 280 V and a
capacitance of 250 AF; two pulses were used. Cells were
diluted in 4 ml of 10% FBS cell growth medium and seeded
on 35-mm dishes. After a 6-h incubation, 10% FBS medium
was replaced by FBS-free medium. At 48 h post-trans-
fection, trypsin type IX (Sigma) was added to a final
concentration of 10 Ag/ml, and cells and media were
harvested after a 30-min incubation at 37 8C. Cells were
lysed by three cycles of freeze/thawing, and the medium-
cell lysate was used to passage the infectious viral progeny
in CaCo-2 cells (type IV for pAVIC-IV, type V for pAVIC-
V, and type VI for pAVIC-VI). The same procedure was
employed to generate the progeny from the original pAVIC,
which corresponds to type XII, to be used as control.
Viral RNA synthesis analysis
Genomic, antigenomic, and subgenomic RNA strands
produced in CaCo-2 cells after infection with different
recombinant viruses at a multiplicity of infection (moi) of
0.01 were titrated by end-point RT-PCR. At 48 h post-
infection, 3  106 infected cells were disrupted in TN buffer
(50 mM Tris–HCl [pH 7.4], 100 mM NaCl) supplemented
with 1% NP40, and after a 1-h incubation at 4 8C, cellular
membranes were recovered by centrifugation at 7000  g.
The pellet was resuspended in 50 Al of TN buffer and
processed for RNA extraction (Boom et al., 1990).
Extracted RNA was titrated (5 Al) by end-point dilution
RT-PCR. For genomic and antigenomic RNA titration,
primers from the HVR were designed so that no mismatches
were present between the target viral RNA and the primer:
primers A1 and A2 for types V and XII; primers A1C (5V-
CCTGCCCCGAGAACAATCAAGC-3V) and A2C (5V-
ATAAGATTCCCAGATTGGCGC-3V) for type IV; and
primers A1F (5V-CCTGCCCCGAGAACAACCAAAT-3V)
and A2 for type VI. Either primer, forward (A1, A1C andA1F) or reverse (A2, and A2C), were included in the RT
step in order to detect both antigenomic RNA() and
genomic RNA(+) strands, respectively. For total positive-
stranded RNA titration (genomic and subgenomic RNA),
we used primers corresponding to the ORF2, with some
modifications (Noel et al., 1995) (Mon244 5V-GGTGTCA-
CAGGACCAAAACC-3V, and Mon245int 5V-CCTGAC-
CAACTAGTGGAAGA-3V), including primer Mon245int
in the RT reaction. Each experiment was performed at least
in duplicate. RNA titers were expressed as the log of RT-
PCR units per 3  106 cells (RT-PCRu/3  106 cells).
Comparison of infectious virus productivity
Infectious viruses in the supernatant medium of infected
cells (released virus) at 48 h pi after infecting with a moi of
0.01 were evaluated using a previously described method
(Abad et al., 2001). Briefly, samples were pretreated with
trypsin and 10-fold dilutions were inoculated onto CaCo-2
cell monolayers grown in 24-well plates. Trypsin was added
to the post-infection medium, and the presence of virus in
the supernatant of each dilution was evaluated by RT-PCR
using specific primers derived from A1 and A2 for each
corresponding virus, 6 days post-infection. All titration
experiments were performed at least in duplicate.
Statistical analysis
Statistical comparisons between means from different
groups were performed using the ANOVA analysis.Acknowledgments
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